1Phillips K A. Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers[J]. JClin Oncol 2000, 18: 107s.
2Brekelmans C, Seynaeve C, Bartels C C, et al. Effectiveness of breast cancer surveillance in BRCA1, BRCA2 gene mutation carriers and women with high familial rlsk[J]. J Clin Oneol,2001, 19: 924.
3Scheuer L, Kauff N, Robson M, et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers[J]. J Clin Oncol, 2002, 20, 1260.
4Warner E, Plewes D. B, Shumak R. S, et al. Comparison of Breast Magnetic Resonance Imaging, Mammography, and Ultrasound for Surveillance of Women at High Risk for Hereditary Breast Cancer[J]. J Clin Oncol, 2001, 19: 3524.
5Hartmann L, Sellers T A, Schaid D J, et al. Efficacy of Bilateral Prophylactic Mastectomy in BRCA1 and BRCA2 Gene Mutation Carriers[J]. J Natl Cancer Inst, 2001, 93: 1633.
6Meijers-Heijboer H, van Geel E, van Putten W L, et al Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med [ J ]2001, 345: 159.
7Rebbeck T R, Levin A M, Eisen A, et al. Breast Cancer Risk After Bilateral Prophylactic Oophorectomy in BRCA1 Mutation Carriers[J]. J Natl Cancer Inst, 1999, 91: 1475.
8Narod S A, Brunet J S, Ghadirian P, et al. Tamoxifen and risk of contralateral breast cancer in BRCA, and BRCA2 mutation carriers., a case-control study[J]. Lancet, 2000, 356:1876.
4Hamzaoui A,Thomas P,Castelnau O,et al.Usefulness oflongitudinal evaluation of CYFRA 2121variations in ad-vanced lung cancer monitoring.Lung Cancer,1997,16(1):191.
5Yang Q,Sakurai T,Mori I,et al.Prognostic significance ofBRCA-1expression in Japanese sporadic breast carcinomas.Cancer,2001,92(1):54-60.
6Tut VM,Braithwaite AL,Angus B,et al.Cyclin D expres-sion in transitional cell carlinoma of the bladder,correlationwith p53,wafl,PRb and Ki67.Br J Cancer,2001,84(2):270-275.
7Friedman E,Kotsopulos J,Lubinski J,et al.Spontaneousand therapeutic abortions and the risk of breast cancer amongBRCA1mutation carriers.Br Cancer Res,2006,15(8):1186-1196.
8Wang X,Ling MT,Guan XY,et al.Identification of a novelfunction of Twist,a bHLH protein,in the development ofacquired taxol resistance in human cancer cells.Oncogene,2004,23:474-482.
9Cheng GZ,Chan J,Wang Q,et al.Twist transcriptionallyup-regulates AKT2in breast cancer cells leading to increasedmigration,invasion,and resistance to paclitaxel.J CancerRes,2007,67:1979-1987.
